As of 2025-10-29, the Relative Valuation of Abbvie Inc (ABBV) is 41.21 USD. This relative valuation is based on P/E multiples. With the latest stock price at 227.54 USD, the upside of Abbvie Inc based on Relative Valuation is -81.9%.
The range of the Relative Valuation is 35.27 - 51.56 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 23.0x | 17.5x |
| Forward P/E multiples | 16.2x - 22.0x | 19.2x |
| Fair Price | 35.27 - 51.56 | 41.21 |
| Upside | -84.5% - -77.3% | -81.9% |
| Date | P/E |
| 2025-10-28 | 106.82 |
| 2025-10-27 | 107.05 |
| 2025-10-24 | 107.03 |
| 2025-10-23 | 107.15 |
| 2025-10-22 | 107.36 |
| 2025-10-21 | 108.63 |
| 2025-10-20 | 108.94 |
| 2025-10-17 | 107.77 |
| 2025-10-16 | 106.51 |
| 2025-10-15 | 106.20 |
| 2025-10-14 | 107.57 |
| 2025-10-13 | 108.12 |
| 2025-10-10 | 108.21 |
| 2025-10-09 | 108.30 |
| 2025-10-08 | 108.56 |
| 2025-10-07 | 109.30 |
| 2025-10-06 | 108.06 |
| 2025-10-03 | 109.81 |
| 2025-10-02 | 111.05 |
| 2025-10-01 | 114.73 |
| 2025-09-30 | 108.70 |
| 2025-09-29 | 104.76 |
| 2025-09-26 | 103.57 |
| 2025-09-25 | 102.59 |
| 2025-09-24 | 103.28 |
| 2025-09-23 | 104.51 |
| 2025-09-22 | 104.50 |
| 2025-09-19 | 104.44 |
| 2025-09-18 | 104.21 |
| 2025-09-17 | 103.66 |
| 2025-09-16 | 101.52 |
| 2025-09-15 | 102.16 |
| 2025-09-12 | 102.50 |
| 2025-09-11 | 103.38 |
| 2025-09-10 | 99.36 |
| 2025-09-09 | 98.78 |
| 2025-09-08 | 98.49 |
| 2025-09-05 | 99.79 |
| 2025-09-04 | 99.99 |
| 2025-09-03 | 99.46 |
| 2025-09-02 | 99.49 |
| 2025-08-29 | 98.77 |
| 2025-08-28 | 97.61 |
| 2025-08-27 | 97.67 |
| 2025-08-26 | 97.82 |
| 2025-08-25 | 97.44 |
| 2025-08-22 | 98.87 |
| 2025-08-21 | 98.35 |
| 2025-08-20 | 98.19 |
| 2025-08-19 | 96.80 |